Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus transtracheal lidocaine for intubation-related hemodynamic changes in treated hypertensive surgical patients
IRCT20141127020112N10Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in hypertension (HTN) (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Systolic blood pressure, Blood pressure and 1 more. Started Mar 2017; status: completed.
02
Drugs
lidocaine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20141127020112N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141127020112N10.